Welcome to the Investor Centre

Arix Bioscience plc (LSE: ARIX) is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.

We are here for two reasons. One is to make a difference to patients’ lives. Second is to generate a return for our investors.

Highlights

£281m

NAV (at 30 Jun 2021)

214p

NAV per share (at 30 Jun 2021)

£164m

Cash (at 30 June 2021)

£115.2m

GPV (at 30 June 2021)

LON:ARIX